As noted in Sandy Bulcher’s review of research supported by our group, we provided funding to Dr. Gerald Downes at the University of Massachusetts, Amherst for his work exploring the neurological consequences of BCAA toxicity in zebrafish.

In MSUD, a mutation in any one of the four genes that encode the Branched-Chain alpha-Ketoacid Dehydrogenase (BCKD) complex, the key enzyme in the metabolism of the branched-chain amino acids, leads to a buildup of these amino acids with profound neurological consequences including seizures, coma, cerebral edema (swelling of the brain), and death. How this occurs is not well understood, and we look to animal models to understand these processes.

Dr. Downes and his team developed a zebrafish model of MSUD, particularly useful because the embryos are transparent and are ready for study after only 4 days of incubation. They expected to observe an abnormal swimming pattern in those zebrafish embryos in which the BCKD gene was disrupted. They did not find this, a result which they attributed to an inadequate dosage of the chemical used to disrupt the gene.

Dr. Downes reports that new and very exciting geneediting technology has now emerged which sidesteps the dosage problem inherent in their previous experiments. It is now very possible to quickly and cheaply mutate target zebrafish genes to perform experiments. They are moving ahead, using this gene-editing strategy to investigate how branchedchain amino metabolism effects nervous system development and function. He also plans to expose the zebrafish to thousands of different chemical compounds and evaluate the impact they have on brain function, in the hopes of identifying substances which may be useful in preventing the neurological damage which occurs with elevated levels of BCAAs. Once they complete their initial experiments, they plan to submit a grant proposal to the National Institutes of Health.

We will continue to follow Dr. Downes’ research with interest.

20th Annual White Horse Beach Charity Golf Tournament

On July 29, 2017 Charlie O’Rouke and his committee held the 20th Annual White Horse Beach Charity Golf Tournament.

Read More

Metformin As A Possible Therapeutic Agent In The Treatment Of MSUD

The MSUD Family Support Group has provided funds to Buck Institute for its preliminary studies investigating metformin

Read More


In the 2016 survey of the membership of the MSUD Family Support Group, research for improved treatments and potential cure was rated “most important” by 90% of the responding members.

Read More


As our legislators headed home for their August break, Rare Disease Legislative Advocates got busy.

Read More

Updates To Nutrition Management Guidelines

The Nutrition Management Guideline for MSUD was first published in 2014. Since that time, there have been reports of new research and experiences that have prompted updates of the guideline.

Read More

Cambrooke Foods Hosts Local Event

Cambrooke has been doing cooking demonstrations, social meet ups and educational events for patients, their families and the clinician’s that support them for many years.

Read More


A Child's Life

Subscribe to our mailing list

Signup To Our Newsletter Signup with your email address to receive news and updates